ZURA – zura bio limited - class a ordinary shares (US:NASDAQ)

News

Zura Bio Limited (NASDAQ: ZURA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Zura Bio Limited (NASDAQ: ZURA) had its price target lowered by analysts at Chardan Capital from $14.00 to $12.00. They now have a "buy" rating on the stock.
Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
Zura Bio Limited (NASDAQ: ZURA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Zura Bio Limited (NASDAQ: ZURA) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $15.00 price target on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com